Vestcor Inc Has $737,000 Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• Vestcor Inc has significantly increased its holdings in Henry Schein, Inc. by 542.0%, acquiring a total of 10,760 shares worth approximately $737,000.
• Several institutional investors have also increased their stakes in Henry Schein, with Franklin Resources Inc. boosting its position by 137.0% during the fourth quarter.
• Wall Street analysts have a consensus rating of "Hold" for Henry Schein, Inc., with a target price of $78.08.

Vestcor Inc boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 542.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,760 shares of the company's stock after acquiring an additional 9,084 shares during the period. Vestcor Inc's holdings in Henry Schein were worth $737,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Invesco Ltd. boosted its position in shares of Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock worth $343,468,000 after buying an additional 17,552 shares during the period. FMR LLC boosted its position in Henry Schein by 6.6% during the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock worth $242,064,000 after acquiring an additional 217,143 shares during the period. Geode Capital Management LLC grew its stake in shares of Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock worth $218,762,000 after purchasing an additional 14,876 shares in the last quarter. Palestra Capital Management LLC acquired a new position in shares of Henry Schein during the fourth quarter valued at $182,988,000. Finally, Fiduciary Management Inc. WI lifted its holdings in Henry Schein by 7.2% in the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock worth $172,193,000 after purchasing an additional 167,990 shares during the period. Institutional investors own 96.62% of the company's stock.

Henry Schein Stock Down 7.4%

NASDAQ HSIC traded down $5.19 on Tuesday, reaching $64.83. The stock had a trading volume of 4,502,243 shares, compared to its average volume of 1,791,472. The company has a market capitalization of $7.89 billion, a price-to-earnings ratio of 20.26, a P/E/G ratio of 2.26 and a beta of 0.81. The business has a 50 day moving average price of $71.41 and a 200 day moving average price of $71.26. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The company had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same quarter last year, the business earned $1.23 EPS. The company's revenue for the quarter was up 3.3% on a year-over-year basis. On average, analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on HSIC shares. Wells Fargo & Company cut their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Leerink Partners set a $75.00 price target on shares of Henry Schein in a report on Monday, July 14th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Finally, Evercore ISI boosted their target price on shares of Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a report on Wednesday, July 9th. Nine research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $78.08.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.